LISATA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.648 USD | -0.46% |
|
-1.93% | -3.01% |
Chart calendar Lisata Therapeutics, Inc.
1a149b4.ZthRffW_Va19Bn61BuZ2Q1JnCaZ5OvqmRXiw5OzsU7M.VOkSDreMZucvbjn8PqcOKjYERtI0ear3cCD3kIaWZfQCvzIotNYcyE5RTg~397e7e1b5343dd142af3c091a53cdb8d
Upcoming events on Lisata Therapeutics, Inc.
Past events on Lisata Therapeutics, Inc.
| 23/04/2024 09:00 pm | Immuno Oncology Europe Summit |
| 17/04/2024 11:00 pm | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 10/04/2024 09:30 pm | FORCE Family Office Healthcare Conference |
| 09/04/2024 07:30 pm | LD Micro Invitational Conference |
| 07/03/2024 09:00 pm | OTC Markets Life Science Investor Forum |
| 01/03/2024 03:00 am | Q4 2023 Earnings Call |
| 01/03/2024 02:35 am | Q4 2023 Earnings Release |
| 26/02/2024 09:45 pm | BIO CEO & Investor Conference |
| 24/01/2024 07:30 pm | Sequire Investor Summit |
| 17/01/2024 | FORCE Family Office Healthcare Conference |
| 04/12/2023 08:30 pm | Noble Capital Markets Emerging Growth Equity Conference |
| 30/11/2023 07:30 am | GCFF Healthcare Investment Conference |
| 14/11/2023 | Jefferies London Healthcare Conference |
| 13/11/2023 08:00 pm | LSX Inv€$tival Showcase |
| 09/11/2023 10:30 am | FORCE Family Office Healthcare Conference |
| 03/11/2023 02:00 am | Q3 2023 Earnings Call |
| 03/11/2023 01:35 am | Q3 2023 Earnings Release |
| 05/10/2023 07:30 pm | Bio Future Conference |
| 03/10/2023 07:45 pm | Bio Century BayHelix East West Biopharma Summit |
| 27/09/2023 05:45 pm | InfoSec World Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -19,1 -19,3 1.13% | -29,0 -30,4 4.62% | -57,5 -59,3 2.98% | -25,5 -27,6 7.54% | -20,4 |
|
EBIT Million USD | Released Forecast Spread | -20,1 -19,7 -1.99% | -19,1 -18,4 -3.8% | -29,1 -30,5 4.7% | -57,6 -43,7 -31.75% | -25,7 -27,2 5.34% | -28,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,4 -19,0 -1.9% | -19,0 -18,3 -4.04% | -29,0 -30,4 4.68% | -56,7 -58,8 3.56% | -23,2 -24,7 6.33% | -25,9 |
|
Net income Million USD | Released Forecast Spread | -19,4 -18,9 -2.44% | -8,15 -12,9 36.7% | -27,5 -29,6 7.34% | -54,2 -56,3 3.69% | -20,8 -23,6 11.65% | -25,9 |
|
EPS USD | Released Forecast Spread | -28,2 -27,4 -2.73% | -7,95 -12,2 34.97% | -7,50 -8,25 9.09% | -10,5 -10,9 3.86% | -2,58 -2,91 11.34% | -3,08 |
| Announcement Date | 05/03/20 | 25/02/21 | 22/03/22 | 30/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -6,84 -8,20 16.57% | -6,61 -7,00 5.53% | -6,71 -7,60 11.67% | -7,32 -7,10 -3.08% | -6,49 -8,30 21.76% | -6,80 -6,60 -2.97% | -6,83 -7,10 3.83% | -5,92 -7,90 25.1% | -5,98 -8,00 25.28% | -6,40 | -6,80 | -7,20 | -8,40 |
|
EBIT Million USD | Released Forecast Spread | -6,85 -8,36 18.09% | -6,62 -7,19 7.94% | -6,72 -6,85 1.91% | -7,33 -6,95 -5.39% | -6,54 -7,47 12.48% | -6,88 -7,17 4.05% | -5,96 -7,89 24.42% | -6,03 -7,52 19.85% | -6,91 | -6,91 | -6,91 | -6,91 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,79 -8,21 17.21% | -6,71 -7,08 5.24% | -6,63 -7,19 7.9% | -37,4 -6,98 -435.61% | -5,99 -8,10 26.04% | -6,19 -6,60 6.26% | -6,36 -6,79 6.38% | -5,26 -7,57 30.46% | -5,37 -7,02 23.59% | -6,06 | -6,26 | -6,46 | -7,11 |
|
Net income Million USD | Released Forecast Spread | -6,79 -8,96 24.14% | -4,23 -7,08 40.28% | -6,63 -7,19 7.9% | -37,4 -6,98 -435.61% | -5,99 -8,10 26.04% | -6,19 -6,60 6.26% | -4,03 -5,69 29.23% | -5,26 -7,57 30.46% | -5,37 -7,02 23.59% | -6,06 | -6,26 | -6,46 | -7,11 |
|
EPS USD | Released Forecast Spread | -1,65 -2,25 26.67% | -1,05 -1,73 39.13% | -1,65 -1,73 4.35% | -7,88 -1,28 -518.04% | -0,76 -1,02 25.49% | -0,77 -0,81 4.94% | -0,50 -0,70 28.57% | -0,65 -0,93 30.11% | -0,66 -0,86 22.81% | -0,73 | -0,75 | -0,77 | -0,84 |
| Announcement Date | 22/03/22 | 05/05/22 | 04/08/22 | 10/11/22 | 30/03/23 | 09/05/23 | 14/08/23 | 02/11/23 | 29/02/24 | - | - | - | - |
More events
Past sector events for Lisata Therapeutics, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LSTA Stock
- Calendar Lisata Therapeutics, Inc.
